EVOLVING SAFETY CONCERNS ASSOCIATED WITH ANTI-DIABETIC DRUGS
AbstractDiabetes Mellitus, a chronic metabolic disorder, is prevalent all over the world nowadays. As a result, it is estimated that it can become an epidemic in some parts of the world soon. The number of affected people could be as double as that of the currently affected patients till the next decade. In order to fulfill the increasing demands of newer, safer, and more effective medications for treatment, prevention, diagnosis, and mitigation of this condition, companies all over the world are trying to introduce new medications in the market. Before entering the market, any new drug undergoes several clinical trials and tests to check and ensure its safety and efficacy. All the associated Adverse Drug Reactions are supervised and monitored by Pharmacovigilance Centers. This ensures that the patients receive safe and effective treatment with minimum or no undesired effects. A brief overview of commonly used hypoglycemic agents and their associated ADRs obtained from publishing data is elucidated in this review.
Article Information
25
747-754
501 KB
535
English
IJPSR
Roma Ghai, Kiran Sharma *, Manisha Prajapati, Ishani Verma, Jaskaran Singh, Harsh Bansal and K. Nagarajan
KIET School of Pharmacy, KIET Group of Institutions, Delhi-NCR, Ghaziabad, affiliated to Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, India.
kiran.sharma@kiet.edu
22 December 2020
11 June 2021
12 June 2021
10.13040/IJPSR.0975-8232.13(2).747-54
01 February 2022
Download